24 Week Pegasys+RBV Treatment SVR in Genotype 1 Predicted by Wk 4 Response (Chronic Hepatitis C)

24 Week Pegasys+RBV Treatment SVR in Genotype 1 Predicted by Wk 4 Response
National AIDS Treatment Advocacy Project - 20% of patients with HCV genotype 1 infection achieved undetectable HCV RNA levels by qualitative

24 Week Pegasys + RBV for Genotype 1: SVR predicted by week 4 response
National AIDS Treatment Advocacy Project - This analysis indicates that a treatment duration of only 24 weeks is effective in the 30% of genotype 1 and 4 patients who achieve an RVR. Thus, treatment duration might be best customized based on HCV RNA level at week 4. 2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) possible in HCV genotype 1 'super-responders'?' Preliminary results of a